We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.54B
AUM Growth
+$120M
Cap. Flow
-$6.56M
Cap. Flow %
-0.43%
Top 10 Hldgs %
29.96%
Holding
232
New
47
Increased
111
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$31.9M
2
LW icon
Lamb Weston
LW
+$24.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.1M
4
GS icon
Goldman Sachs
GS
+$17.5M
5
FCNCA icon
First Citizens BancShares
FCNCA
+$16.3M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$31.8M
2
SNPS icon
Synopsys
SNPS
+$26.6M
3
KIM icon
Kimco Realty
KIM
+$23.1M
4
NI icon
NiSource
NI
+$21.1M
5
UNP icon
Union Pacific
UNP
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 18.76%
2 Technology 16.54%
3 Financials 14.35%
4 Industrials 13.12%
5 Consumer Staples 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSCO
51
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$8.81M 0.57%
429,972
+19,912
+5% +$407K
BSCP
52
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$8.8M 0.57%
437,178
+21,631
+5% +$434K
DKS icon
53
Dick's Sporting Goods
DKS
$17.5B
$8.78M 0.57%
72,977
+66,838
+1,089% +$7.53M
BSCQ icon
54
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.66B
$8.77M 0.57%
463,242
+23,896
+5% +$449K
BMY icon
55
Bristol-Myers Squibb
BMY
$133B
$8.74M 0.57%
121,457
+101,616
+512% +$7.66M
BSCR icon
56
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
$8.62M 0.56%
453,516
+23,287
+5% +$439K
BSCS icon
57
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.56B
$8.57M 0.56%
436,905
+21,503
+5% +$418K
BG icon
58
Bunge Global
BG
$20.4B
$8.51M 0.55%
85,246
-7
-0% -$672
BSCV icon
59
Invesco BulletShares 2031 Corporate Bond ETF
BSCV
$1.76B
$8.48M 0.55%
538,318
+32,696
+6% +$512K
BSCT icon
60
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.91B
$8.43M 0.55%
474,132
+17,694
+4% +$312K
BSCU icon
61
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.65B
$8.36M 0.54%
523,882
+20,143
+4% +$320K
CNI icon
62
Canadian National Railway
CNI
$76.9B
$8.33M 0.54%
70,062
+2,491
+4% +$298K
BSCW icon
63
Invesco BulletShares 2032 Corporate Bond ETF
BSCW
$1.48B
$8.29M 0.54%
+416,603
New +$8.18M
HUM icon
64
Humana
HUM
$43.7B
$8.08M 0.53%
15,779
+384
+2% +$202K
RPM icon
65
RPM International
RPM
$13.7B
$7.64M 0.5%
+78,355
New +$7.6M
MSI icon
66
Motorola Solutions
MSI
$72.3B
$6.94M 0.45%
26,928
-199
-0.7% -$49.7K
P
67
Everpure Inc
P
$25.7B
$5.8M 0.38%
216,924
+129,816
+149% +$3.77M
FSLR icon
68
First Solar
FSLR
$22.7B
$5.07M 0.33%
+33,845
New +$5.01M
SPHD icon
69
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.34B
$2.93M 0.19%
66,767
+2,327
+4% +$100K
HALO icon
70
Halozyme
HALO
$9.79B
$2.63M 0.17%
46,272
-4,659
-9% -$239K
NVDA icon
71
NVIDIA
NVDA
$4.86T
$2.6M 0.17%
177,700
-33,940
-16% -$498K
DECK icon
72
Deckers Outdoor
DECK
$13.2B
$2.42M 0.16%
36,354
+4,590
+14% +$278K
MSFT icon
73
Microsoft
MSFT
$3.45T
$2.37M 0.15%
9,886
-73,036
-88% -$17.5M
MTDR icon
74
Matador Resources
MTDR
$6.2B
$2.37M 0.15%
41,406
-18,122
-30% -$1.14M
MOAT icon
75
VanEck Morningstar Wide Moat ETF
MOAT
$11.9B
$2.21M 0.14%
34,059
+1,488
+5% +$96.5K

Similar funds

Cookson Peirce & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Cookson Peirce & Co held 232 positions worth $1.54B, up 8.4% from $1.42B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cookson Peirce & Co's Q4 2022 filing shows 47 new, 111 increased, 37 reduced and 30 closed positions. Its largest new stake was Lamb Weston: 283,180 shares worth $25.3M. The largest sale was AstraZeneca, an estimated $31.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Cookson Peirce & Co's largest Q4 2022 buy was Lamb Weston: 283,180 shares worth $25.3M.
  • Cookson Peirce & Co added most to Merck in Q4 2022, an estimated $31.9M increase.
  • Cookson Peirce & Co's biggest Q4 2022 reduction was AstraZeneca, cutting an estimated $31.8M.
  • Cookson Peirce & Co fully exited Synopsys in Q4 2022, selling an estimated $26.6M.
  • Cookson Peirce & Co's ten largest holdings make up 30% of its $1.54B portfolio in Q4 2022.
  • Cookson Peirce & Co opened 47 new positions and closed 30 in Q4 2022.
  • Cookson Peirce & Co's portfolio value rose 8.4% quarter-over-quarter to $1.54B.

Based on Cookson Peirce & Co's 13F filing for Q4 2022, filed 31 Jan 2023.